Literature DB >> 19753952

Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.

Holly C Felix1, Janet Bronstein, Zoran Bursac, M Kathryn Stewart, H Russell Foushee, Joshua Klapow.   

Abstract

OBJECTIVES: Family planning (FP) clinics are important access points for cervical cancer screening and referrals for follow-up care for abnormal Papanicolaou (Pap) smears for a substantial number of U.S. women. Because little is known about referral and facilitation practices in these clinics or client action based on referrals, we sought to determine FP provider referral and facilitation practices when seeing FP clients with abnormal Pap smear results, and FP client follow-up for abnormal Pap smears due to FP provider referrals.
METHODS: We conducted a mail survey of Medicaid-enrolled FP providers in Arkansas and Alabama, and conducted a telephone survey with a sample of FP clients of those providers responding to the provider survey.
RESULTS: Major provider factors associated with referral included rural location, health department and clinic institutional setting, large Title X practice/clinic size, and high FP clinic focus. Major factors associated with facilitation included rural location, non-physician specialty, health department and clinic institutional setting, and small Title X clinic size. Of women reporting abnormal results, 62.4% reported follow-up care. Of those who received follow-up care, 40.0% received some care and a referral from their FP provider. A major factor associated with clients seeking follow-up care was being told by their FP provider where to go for follow-up care. Age was a major factor associated with clients actually obtaining follow-up care.
CONCLUSIONS: Where follow-up care is not available at the FP site, referrals are critical and are a major factor associated with whether women seek care for the condition. Interventions to increase follow-up rates should focus on provider and system features, rather than clients.

Entities:  

Mesh:

Year:  2009        PMID: 19753952      PMCID: PMC2728666          DOI: 10.1177/003335490912400516

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

Review 1.  Physician response to surveys. A review of the literature.

Authors:  S E Kellerman; J Herold
Journal:  Am J Prev Med       Date:  2001-01       Impact factor: 5.043

Review 2.  Using the essential services as a foundation for performance measurement and assessment of local public health systems.

Authors:  L C Corso; P J Wiesner; P K Halverson; C K Brown
Journal:  J Public Health Manag Pract       Date:  2000-09

Review 3.  Trust in physicians and medical institutions: what is it, can it be measured, and does it matter?

Authors:  M A Hall; E Dugan; B Zheng; A K Mishra
Journal:  Milbank Q       Date:  2001       Impact factor: 4.911

4.  U.S. agencies providing publicly funded contraceptive services in 1999.

Authors:  Lawrence B Finer; Jacqueline E Darroch; Jennifer J Frost
Journal:  Perspect Sex Reprod Health       Date:  2002 Jan-Feb

Review 5.  Improving adherence to abnormal Pap smear follow-up.

Authors:  P D Abercrombie
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2001 Jan-Feb

Review 6.  American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

Authors:  Debbie Saslow; Carolyn D Runowicz; Diane Solomon; Anna-Barbara Moscicki; Robert A Smith; Harmon J Eyre; Carmel Cohen
Journal:  CA Cancer J Clin       Date:  2002 Nov-Dec       Impact factor: 508.702

Review 7.  Cervical cancer: disparities in screening, treatment, and survival.

Authors:  Elizabeth I O Garner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-03       Impact factor: 4.254

Review 8.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

9.  Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers.

Authors:  Judith H Hibbard; Jean Stockard; Eldon R Mahoney; Martin Tusler
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

10.  2006 consensus guidelines for the management of women with abnormal cervical screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

View more
  5 in total

1.  Organization Communication Factors and Abnormal Mammogram Follow-up: a Qualitative Study Among Ethnically Diverse Women Across Three Healthcare Systems.

Authors:  Jazmine D Kenny; Leah S Karliner; Karla Kerlikowske; Celia P Kaplan; Ana Fernandez-Lamothe; Nancy J Burke
Journal:  J Gen Intern Med       Date:  2020-06-29       Impact factor: 5.128

Review 2.  Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.

Authors:  Jane Zapka; Stephen H Taplin; Rebecca Anhang Price; Caroline Cranos; Robin Yabroff
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Providing general and preconception health care to low income women in family planning settings: perception of providers and clients.

Authors:  Janet M Bronstein; Holly C Felix; Zoran Bursac; M Kathryn Stewart; H Russell Foushee; Joshua Klapow
Journal:  Matern Child Health J       Date:  2012-02

4.  Outcomes of cardiovascular disease risk factor screening and referrals in a family planning clinic.

Authors:  Cheryl L Robbins; Thomas C Keyserling; Stephanie Jilcott Pitts; John Morrow; Merry-K Moos; Larry F Johnston; Sherry L Farr
Journal:  J Womens Health (Larchmt)       Date:  2014-12-17       Impact factor: 2.681

5.  Referral Practices Among U.S. Publicly Funded Health Centers That Offer Family Planning Services.

Authors:  Marion W Carter; Cheryl L Robbins; Loretta Gavin; Susan Moskosky
Journal:  J Womens Health (Larchmt)       Date:  2018-01-29       Impact factor: 2.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.